These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29110212)

  • 1. Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy.
    Dorsey SG
    Neurotherapeutics; 2018 Jan; 15(1):176-177. PubMed ID: 29110212
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.
    Bruna J; Videla S; Argyriou AA; Velasco R; Villoria J; Santos C; Nadal C; Cavaletti G; Alberti P; Briani C; Kalofonos HP; Cortinovis D; Sust M; Vaqué A; Klein T; Plata-Salamán C
    Neurotherapeutics; 2018 Jan; 15(1):178-189. PubMed ID: 28924870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence.
    Kawashiri T; Mine K; Kobayashi D; Inoue M; Ushio S; Uchida M; Egashira N; Shimazoe T
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial.
    Arslan S; Zorba Bahceli P; İlik Y; Artaç M
    Eur J Oncol Nurs; 2020 Oct; 48():101827. PubMed ID: 32932009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxaliplatin-induced peripheral neuropathy: how to create a barrier?].
    Taïb S; Durand J; Brunet I
    Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():33-37. PubMed ID: 33052091
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population.
    Zribi A; Nasr SB; Hamdi S; Ayari J; Fendri S; Balti M; Haddaoui A
    Pan Afr Med J; 2020; 35():83. PubMed ID: 32537086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
    Kang L; Tian Y; Xu S; Chen H
    J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.
    Zamami Y; Niimura T; Kawashiri T; Goda M; Naito Y; Fukushima K; Ushio S; Aizawa F; Hamano H; Okada N; Yagi K; Miyata K; Takechi K; Chuma M; Koyama T; Kobayashi D; Shimazoe T; Fujino H; Izawa-Ishizawa Y; Ishizawa K
    Biomed Pharmacother; 2022 Apr; 148():112744. PubMed ID: 35240525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
    Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
    Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of TRPA1 in acute peripheral neuropathy characteristically induced by oxaliplatin].
    Nakagawa T; Zhao M; Shirakawa H; Kaneko S
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):76-80. PubMed ID: 23391546
    [No Abstract]   [Full Text] [Related]  

  • 12. Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats.
    Paniagua N; Girón R; Goicoechea C; López-Miranda V; Vela JM; Merlos M; Martín Fontelles MI
    Eur J Pain; 2017 Jan; 21(1):61-72. PubMed ID: 27341510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review.
    Gebremedhn EG; Shortland PJ; Mahns DA
    BMC Cancer; 2018 Apr; 18(1):410. PubMed ID: 29649985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence from basic studies on mechanisms and treatment drugs for oxaliplatin-induced peripheral neuropathy].
    Egashira N; Kawashiri T; Oishi R
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):66-70. PubMed ID: 23391544
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.
    Hsu SY; Huang WS; Lee SH; Chu TP; Lin YC; Lu CH; Beaton RD; Jane SW
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12976. PubMed ID: 30536809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
    Ushio S; Kawashiri T; Egashira N
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
    [No Abstract]   [Full Text] [Related]  

  • 17. A-Fibers Mediate Cold Hyperalgesia in Patients with Oxaliplatin-Induced Neuropathy.
    Forstenpointner J; Oberlojer VC; Naleschinski D; Höper J; Helfert SM; Binder A; Gierthmühlen J; Baron R
    Pain Pract; 2018 Jul; 18(6):758-767. PubMed ID: 29222932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive Effects of Renin-angiotensin System Inhibitors on Oxaliplatin-induced Peripheral Neuropathy: A Retrospective Observational Study.
    Uchida M; Kawazoe H; Takatori S; Namba H; Uozumi R; Tanaka A; Kawasaki H; Araki H
    Clin Ther; 2018 Jul; 40(7):1214-1222.e1. PubMed ID: 29983264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation.
    Uchida M; Ushio S; Niimura T; Takechi K; Kawazoe H; Hidaka N; Tanaka A; Araki H; Zamami Y; Ishizawa K; Kitamura Y; Sendou T; Kawasaki H; Namba H; Shibata K; Tanaka M; Takatori S
    Biol Pharm Bull; 2022 Feb; 45(2):226-234. PubMed ID: 34803077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
    Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
    ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.